Product Characterization Assay Package - Interlot And Biosimilar Comparability
Source: MilliporeSigma
Monoclonal antibodies (mAbs) are highly complex biomolecules easily affected by changes in the biopharmaceutical manufacturing process. Something as simple as a temperature fluctuation can produce a change in higher order structure (HOS) that renders the mAb less active or inactive.
Whether your mAb is an original product or a biosimilar, our comparability studies are designed to ensure robust and reproducible mAb production. Testing services performed meet GMP guidelines and include:
- Comparability between a biosimilar and an original product
- Comparability between different production facilities or different production lots
access the Datasheet!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.
Subscribe to Biosimilar Development
X
Subscribe to Biosimilar Development
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more